Cryosurgery in the management of prostate cancer;Criocirugía en el tratamiento del cáncer de próstata

Actas Urologicas Espanolas

Volumn 31, Issue 3, 2007, Pages 211-232

  Pontones Moreno, J L ^a   Morera Martinez J F ^a   Vera Donoso, C D ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cryosurgery; Prostate cancer

Indexed keywords

EID: 34250306339     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(07)73627-6     Document Type: Review

References (90)

1. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002; 60(suppl 2A):3-11.
2. Soanes WA, Gonder MJ, Shulman S. Apparatus and technique for cryosurgery of the prostate. J Urol. 1966;96:508-511.
3. Flocks RH, Nelson CM, Boatman DL. Perineal cryosurgery for prostatic carcinoma. J Urol. 1972; 108:933-935.
4. Porter MP, Ahaghotu CA, Loening SA, See WA. Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: A 20-year followup. J Urol. 1997;158:1466-1469.
5. Onik GM, Cohen JK, ReyesGD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291-1299.
6. Saliken JC, Donnelly BJ, Rewcastle JC. The evolution and state of modern technology for prostate cryosurgery. Urology. 2002;62(suppl 2A):26-33.
7. Ellis DS. Criosurgery as primary treatment for lacalized prostate cancer: A community hospital experience. Urology. 2002;60(suppl 2A):34-39.
8. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171.
9. Mazur P. Cryobiology: The freezing of biological systems. Science. 1970;168:939-949.
10. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(Suppl 1):40-49.
11. Whitaker DK. Mechanism of tissue destruction following cryosurgery. Am R Coll Surg England. 1984;66:313-318.
12. Zook N, Hussman J, Brown R, Russell R, Kucan J, Roth A, et al. Microcirculatory studies of frosbite injury. Ann Plast Surg. 1998;40:246-253.
13. Hollister WR, Mathew AJ, Baust JG, van Buskirk RG: The effects of freezing on cell viability and mechanism of cell death in an in vitro human prostate cancer cell line. Mol Urol. 1998;2:13-18.
14. Dachs GU, Stratford IJ. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer. 1996;Suppl 27: S126-132
15. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU International 2005, 95:1187-1191.
16. Mazur P. Freezing of living cells: Mechanism and implications. Am J Phisyol. 1984; 143:125-142.
17. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48:441-447.
18. Bischof JC, Cristov K, Rubinsky BA: A morphological study of the cooling rate response of normal and neoplastic human liver tissue: Criosurgical implications. Cryobiology. 1993;30:482-492.
19. Hong J, Rubinsky B. Patterns of ice formation in normal and malignant breast tissue. Cryobiolgy. 1994, 31:109-120.
20. Keanini GR, Rubinsky B. Optimization of multiprobe cryosurgery. J Heat Trans. 1992:114:796-802.
21. Yang WH, Peng HH, Chang HC, Shen Y, Wu CL, Chang CH. An in vitro monitoring system for simulated thermal process in cryosurgery. Cryobiology. 2000;40:159-170.
22. Uchida M, Imaide I, Sugimoto K. Uehara H, Watanabe H: Percutaneous cryosurgery for renal tumors. Br J Urol. 1995;75:132-137.
23. Smith DJ, Fahssi WM, Swanlund DJ, Bischof JC. A parametric study of freezing injury in AT-1 rat prostate tumor cells. Cryobiology. 1999;39:13-28.
24. Shinohara K, Connolly JA, Presti JC. Jr, Carroll PR: Cryosurgical treatment of localized prostate cancer (Stages T1 to T4): Preliminary results. J Urol. 1996;156:115-120.
25. Dilley AV, Dy D, Walters A, Copeland S, Gilles AE, Morris RW, et al: Laboratory and animal model evaluation of Criotech LCS 2000 in hepatic cryosurgery. Cryobiology. 1993,30:74-85.
26. Patel BG, Parsons CL, Bidair M, Schmidt JD. Cryoablation for carcinoma of the prostate. J Surg Oncol. 1996;63:256-264.
27. Connolly JA, Shinohara K, Presti JC, Carroll PR. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996;23:623-631.
28. Larson TR, Robertson DW, Corica A, Bostwick DG. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology. 2000;55:547-552.
29. Pisters LL, Dinney CPN, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, et al: A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol. 1999;161:509-514.
30. Sandison GA. Future directions for cryosurgery computer treatment planning. Urology. 2002;60(suppl 2A):50-55.
31. Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT. Jr. Technique of US-guided percutaneous cryoablation of prostate cancer. Radiology. 1994;192:769-776.
32. Baust J, Gage AA, Ma H, Zhang C. Minimally invasive cryosurgery-technologycal advances. Cryobilogy. 1997;34:373-384.
33. Rewcastle JC, Sandison GA, Saliken JC, Donnelly BJ, McKinnon JG. Considerations during clinical operation of two commercially available cryomachines. J Surg Oncol. 1999;71:106-111.
34. Han K, CohenJK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170: 1126-1130.
35. Chin JL, Downey DB, Mulligan M, Fenster A: Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol. 1998;159:910-914.
36. Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166:853-855.
37. Mala T, Samset E, Aurdal I, Gladhaug I, Edwin B, Soreide O. Magnetic resonance imaging-estimated three-dimensional temperature distribution in liver cryolesions. A study of cryolesion characteristics assumed necessary for tumor ablation. Cryobiology. 2001;43:268-275.
38. Daniel BL, ButtsK, Block WF. Magnetic resonance imaging of frozen tissues: temperature-dependent MR signal characteristics and relevance for MR monitoring cryosurgery. Magn Reson Med. 1999;41:627-630.
39. Cohen J, Miller RJ, Shuman BA. Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995, 45:861-864.
40. Wong WS, Chinn DO, Chinn M, Tom WL, Tom W. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79: 963-974.
41. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU 2004;93:14-18.
42. Rabin Y, Lung DC, Stahovich TF. Computerized planning of cryosurgery using cryoprobes and cryoheaters. Technol Cancer Res Treat. 2004;3:229-243.
43. Shinohara K. Prostate cancer: cryotherapy. Urol Clin N Am. 2003;30:725-736.
44. Ahmed S, Lindsey B, Davies J. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Prostate Cancer and Prostatic Diseases. 2005;8:31-35.
45. Da la Taille A, Katz AE. Cryosurgery: is it an effective option for patients failing radiation? Curr Opin Urol. 2000;10:409-413.
46. Schmidt JD, Doyle J, Larison S: Prostate Cryoablation: Update 1998. CA Cancer J Clin. 1998;48:239-253.
47. Pisters LL, von Eschenbach AC, Scott SM, Shellie M, Swanson DA, Dinney CP, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157:921-925.
48. Cohen JK. Cryosurgery of the Prostate: Techniques and Indications. Rev Urol. 2004;6(suppl 4):S20-S26.
49. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109-114.
50. Katz AE, Rewcastle JC. The current and potential role of cryoablation as a primary therapy for localized prostate cancer Curr Oncol Rep. 2003:5:231-238.
51. Rees J, Patel B, Macdonagh R, Persad R. Cryosurgery for prostate cancer. BJU 2004;93:710-714.
52. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical Ablation of the Prostate: High-Risk Patient Outcomes. Cancer. 2005;103:1625-1630.
53. Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll PC. The efficacy of cryosurgical ablation of prostate cancer: the University of California San Francisco experience. J Urol. 1999;162:427-432.
54. Pisters LL, Perrotte P, Scott SM, Greene GF, von Eschenbach AC, Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999;17:2514-2520.
55. Merrick GS, Wallner KE, Butler WM. Prostate cryotherapy: more questions than answers Urology. 2005;66:9-15.
56. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JNJr. Five year retrospective multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001;57:518-523.
57. Escudero Barrilero A, Arias Funes F, Rodriguez Patrón Rodríguez R, García González R. Criocirugía (tercera parte). revisión de la literatura y nuestra experiencia. (II). Arch Esp Urol 2005;58:1003-1029.
58. Aus G, Pileblad E, Hugosson J. Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. Eur Urol. 2002;42:133-138.
59. Weider J, Schmidt JD, Casola G, Van Sonnenberg E, Stainken BF, Parsons CL. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: Preliminary results. J Urol. 1995;154:435-441.
60. Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following ciryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol. 1998;159:477-484.
61. Bahn DK, Lee F, Solomon MH, Gontina H, Klionsky DL, Lee FT Jr. Prostate cancer: US-guided percutaneous cyoablation. Radiology. 1995;194:551-556.
62. Shinohara K, Rhee B, Presti JC. Jr, Carroll PR. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997;158:2206-2209.
63. Leibovich BC, Blute ML, Bostwick DG, Wilson TM, Pisansky TM, Davis BJ, et al. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology. 2000;56:726-729.
64. Saliken JC, Donnelly BJ, Brasher P, Ali-Ridha N, Ernst S, Robinson J. Outcome and Safety of Transrectal US-guided Percutaneous Cryotherapy for Localized Prostate Cancer. J. Vasc Interv Radiol. 1999;10:199-208.
65. Cohen JK, Miller RJ, Rooker GM, Shuman BA. Cryosurgical ablation of the prostate: Two-year prostate-specific antigen and biopsy results. Urology. 1996;47:395-401.
66. Shuman BA, Cohen JK, Miller RJ Jr, Rooker GM, Olson PR. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate. J Urol. 1997;157:552-555.
67. Grampsas SA, Miller GJ, Crawford ED. Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology. 1995;45:936-941.
68. a parte. Arch Esp Urol. 2004;57:1073-1090.
69. Littrup PJ, Mody A, Sparschu R, Prchevski P, Montie J, Zingas AP, et al: Prostatic cryotherapy: Ultrasonographic and pathologic correlation in the canine model. Urology. 1994;44:175-183.
70. Leibovici D, Zisman A, Lindner A, Stav K, Siegel YI. PSA elevation during prostate cryosurgery and subsequent decline. Urol Oncol. 2005;23:8-11.
71. Coogan CL, McKiel CF. Percutaneous Cryoablation of the Prostate: Preliminary Results After 95 Procedures. J Urol. 1995;154:1813-1817.
72. Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PMA, Robinson JW, et al. A prospective trial of cryosurgical ablation of the prostate: Five-year results. Urology. 2002;60:645-649.
73. Gould RS. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol. 1999;162:1653-1657.
74. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005;173:373-379.
75. Greene GF, Pisters LL, Scott SM, von Eschenbach AC. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol. 1998;160:86-90.
76. Ghafar MA, Johnson CW, de la Taille A, Benson MC, Bagiella E, Fatal M, et al. Salvage cryotherapy using an argon based system for locally recurTent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166:1333-1338.
77. Bales GT, Willians MJ, Sinner M, Thisted RA, Chodak GW. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation failure. Urology. 1995;46:676-680.
78. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, von Eschenbach AC, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002;20: 2664-2671.
79. Chin JL, Pander SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001;165:1937-1942.
80. Chin JL, Touma N, Pautler SE, Guram KS, Bella AJ, Downey DB et al. Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol. 2003;170:1199-1202.
81. Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2:111-114.
82. Rukstalis DB, GoldknoffJL, Crowley EM, Garcia FU. Prostate cryoablation: A scientific rationale for future modifications. Urology. 2002;60(suppl 2A):19-25.
83. Janzen NK, Han KR, Perry KT, Said JW, Schulam PG, Belldegrun AS. Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol. 2005;19:520-525.
84. a):12-18.
85. Green TC. Avances en crioterapia 2004. Criobiología. Arch Esp Urol. 2005;58:589-596.
86. Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology. 1995;45:932-935.
87. Perrotte P, Litwin MS, McGuire EJ, Scott SM, von Eschenbach AC, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J. Urol. 1999;162:398-402.
88. Clarke DM, Baust JM, Van Buskirk RG. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 2001;42:274-285.
89. Chao BH, He X, Bischof JC. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. Cryobiology. 2004;49:10-27.
90. Pham L, Dahiya R, Rubinsky B: An in vivo study of antifreeze protein adjuvant cryosurgery. Cryobiology. 1999;38: 169-175.